February 20, 2018 / 11:22 PM / 3 months ago

BRIEF-Prometic Announces Realignment Of Its Clinical Program Priorities For 2018

Feb 20 (Reuters) - Prometic Life Sciences Inc:

* PROMETIC ANNOUNCES REALIGNMENT OF ITS CLINICAL PROGRAM PRIORITIES FOR 2018

* PROMETIC LIFE SCIENCES - AS PART OF REALIGNMENT, CO TERMINATED PBI-4050 CLINICAL TRIAL IN CYSTIC FIBROSIS RELATED DIABETES

* PROMETIC LIFE SCIENCES INC - AS PART OF REALIGNMENT, CO IS EVALUATING NEED TO CONTINUE OTHER ON-GOING CLINICAL PROGRAMS WITH PBI-4050

* PROMETIC LIFE SCIENCES-EVALUATING CLINICAL DEVELOPMENT STRATEGY REGARDING FOLLOW-ON COMPOUNDS WHICH SHARE SAME UNIQUE MECHANISM OF ACTION WITH PBI-4050 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below